EUVIMEDEUVIMED entdecken
Open Access

Treating myocardial infarction via a nano-ultrasonic contrast agent-mediated high-efficiency drug delivery system targeting macrophages

Zhen Ma iD, Ming Li iD, Rui Guo iD, Yu Tian iD, Yongbin Zheng iD, Bingxin Huang iD, Yi You iD, Qing Xu iD, Ming Cui iD, Li Shen iD, Feng Lan iD, Hang Yang iD und 8 weitere

Science Advances · 03.01.2025 · 11 (1)

DOI: 10.1126/sciadv.adp7126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 03.01.2025. Verfasst von Zhen Ma und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Peking University Third Hospital, Beijing 100191, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Macrophages, Contrast Media, Drug Delivery Systems. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following myocardial infarction (MI), the accumulation of CD86-positive macrophages in the ischemic injury zone leads to secondary myocardial damage. Precise pharmacological intervention targeting this process remains challenging. This study engineered a nanotherapeutic delivery system with CD86-positive macrophage-specific targeting and ultrasound-responsive release capabilities. A folic acid (FA)–modified ultrasound-responsive gene/drug delivery system, assembled from DOTAP, DSPE-PEG2000-FA, cholesterol, and perfluorohexane (PFH)—termed FA-PNBs—was developed to codeliver small interfering RNA of STAT1 (siSTAT1) and the small-molecule nitro-oleic acid (OA-NO 2 ) into CD86-positive macrophages. Upon irradiation with low-intensity focused ultrasound, FA-PNBs release siSTAT1 and OA-NO 2 at the ischemic injury zone. The results demonstrated the system’s precise targeting and efficient delivery capabilities. The combined modulation of OA-NO 2 and siSTAT1 optimizes the immune microenvironment in the infarcted region, alleviates ventricular remodeling, preserves cardiac function, and holds promise for clinical intervention strategies after MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionMacrophagesContrast MediaDrug Delivery SystemsAnimalsMiceSTAT1 Transcription FactorFolic AcidNanoparticlesRNA, Small InterferingDisease Models, Animal

Substanzen

Contrast MediaSTAT1 Transcription FactorFolic AcidStat1 protein, mouseRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Peking University Third Hospital, Beijing 100191, China.
  • Joint International Research Center of Translational and Clinical Research, Beijing 100142, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Molecular Pharmaceutics and Drug Delivery System, and School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Ultrasound Medical Center, Lanzhou University Second Hospital, Gansu Province Clinical Research Center for Ultrasonography, Gansu Province Medical Engineering Research Center for Intelligence Ultrasound, Lanzhou 730000,…
  • Peking University Shenzhen Graduate School, Shenzhen 518055, China.
  • Department of Cardiology, Peking University Third Hospital, Beijing 100191, China.

ORCID-Profile: Zhen Ma, Ming Li, Rui Guo, Yu Tian, Yongbin Zheng, Bingxin Huang, Yi You, Qing Xu, Ming Cui, Li Shen, Feng Lan, Hang Yang, Rucong Liu, Tao Yang, Feng Wan, Qihua He, Xiao Huo, Youkun Bi, Yingying Zhang, Yunpeng Ling

Zitieren

APA

Ma, Z., Li, M., Guo, R., Tian, Y., Zheng, Y., Huang, B., You, Y., Xu, Q., Cui, M., Shen, L., Lan, F., Yang, H., Liu, R., Yang, T., Wan, F., He, Q., Huo, X., Bi, Y., Zhang, Y., & Ling, Y. (2025). Treating myocardial infarction via a nano-ultrasonic contrast agent-mediated high-efficiency drug delivery system targeting macrophages. Science Advances, 11(1). https://doi.org/10.1126/sciadv.adp7126

Vancouver

Ma Z, Li M, Guo R, Tian Y, Zheng Y, Huang B, et al. Treating myocardial infarction via a nano-ultrasonic contrast agent-mediated high-efficiency drug delivery system targeting macrophages. Science Advances. 2025;11(1). doi:10.1126/sciadv.adp7126

BibTeX
@article{Ma2025,
  author = {Ma, Zhen and Li, Ming and Guo, Rui and Tian, Yu and Zheng, Yongbin and Huang, Bingxin and You, Yi and Xu, Qing and Cui, Ming and Shen, Li and Lan, Feng and Yang, Hang and Liu, Rucong and Yang, Tao and Wan, Feng and He, Qihua and Huo, Xiao and Bi, Youkun and Zhang, Yingying and Ling, Yunpeng},
  title = {Treating myocardial infarction via a nano-ultrasonic contrast agent-mediated high-efficiency drug delivery system targeting macrophages},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {1},
  doi = {10.1126/sciadv.adp7126}
}
Kostenlos starten →